- In June 2024, BioHorizons introduced the Tapered Pro Conical dental implant, featuring a tapered body and thread design that enhances stability. This versatile implant supports both single tooth and full arch restorations, strengthening BioHorizons’ position in the dental implant market by offering clinicians a reliable solution that meets diverse patient needs and expands treatment options
- In June 2024, Royal Philips launched the Duo Venous Stent System, a cutting-edge device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency. Following its FDA premarket approval, this advanced stent system is set to improve patient outcomes and broaden treatment possibilities, thereby reinforcing Philips’ competitive edge in the vascular intervention device market
- In November 2023, Medtronic received FDA approval for its Symplicity Spyral renal denervation system, aimed at managing hypertension through a minimally invasive radiofrequency procedure that targets overactive kidney nerves. This approval enhances Medtronic’s portfolio in the hypertension treatment market, offering a novel, less invasive therapeutic option and potentially transforming clinical management of resistant high blood pressure
